Despite treatment advances, ‘much to improve upon’ in high-risk neuroblastoma

As outcomes for high-risk neuroblastoma improve, refining treatment approaches in order to reduce late-term effects will be key, according to Giselle Sholler, MD.

Read more: https://www.healio.com/news/hematology-oncology/20200709/despite-treatment-advances-much-to-improve-upon-in-highrisk-neuroblastoma